Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | $0.70 | $0.72 | $0.71 |
| Q2 2026 | 3 | $0.66 | $0.79 | $0.72 |
| Q3 2026 | 1 | $0.79 | $0.83 | $0.81 |
| Q4 2026 | 1 | $0.91 | $0.95 | $0.93 |
| Q1 2027 | 1 | $0.76 | $0.79 | $0.77 |
| Q2 2027 | 1 | $0.68 | $0.70 | $0.69 |
Phibro Animal Health Corp. last posted its earnings results on Wednesday, February 4th, 2026. The company reported $0.87 earnings per share for the quarter, topping analysts' consensus estimates of $0.69 by $0.18. The company had revenue of 373.91 M for the quarter and had revenue of 1.30 B for the year. Phibro Animal Health Corp. has generated $1 earnings per share over the last year ($1.19 diluted earnings per share) and currently has a price-to-earnings ratio of 23.24. Phibro Animal Health Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/04/2026 | Q2 2026 | $0.69 | $0.68 | -0.01 | $355.64 M | $373.91 M |
| 11/05/2025 | Q1 2026 | $0.59 | $0.65 | 0.06 | $347.01 M | $363.89 M |
| 08/27/2025 | Q4 2025 | $0.52 | $0.42 | -0.1 | $362.38 M | $378.70 M |
| 05/07/2025 | Q3 2025 | $0.52 | $0.52 | 0 | $352.19 M | $347.83 M |
| 02/05/2025 | Q2 2025 | $0.40 | $0.08 | -0.32 | $292.26 M | $309.26 M |
| 11/06/2024 | Q1 2025 | N/A | $0.17 | N/A | $246.70 M | $260.43 M |
| 08/28/2024 | Q4 2024 | $0.34 | $0.02 | -0.32 | $260.49 M | $273.16 M |
| 05/08/2024 | Q3 2024 | $0.29 | $0.21 | -0.08 | $253.65 M | $263.22 M |
| 02/07/2024 | Q2 2024 | $0.27 | $0.03 | -0.24 | N/A | $249.94 M |
| 11/08/2023 | Q1 2024 | $0.21 | -$0.20 | -0.41 | N/A | $231.35 M |
| 08/30/2023 | Q4 2023 | $0.40 | $0.28 | -0.12 | N/A | $255.05 M |
| 05/03/2023 | Q3 2023 | $0.34 | $0.25 | -0.09 | N/A | $245.67 M |
| 02/08/2023 | Q2 2023 | $0.30 | $0.18 | -0.12 | N/A | $244.65 M |
| 11/09/2022 | Q1 2023 | $0.26 | $0.10 | -0.16 | N/A | $232.52 M |
| 08/24/2022 | Q4 2022 | $0.40 | $0.18 | -0.22 | N/A | $255.27 M |
| 05/04/2022 | Q3 2022 | $0.35 | $0.44 | 0.09 | N/A | $239.62 M |
| 02/09/2022 | Q2 2022 | $0.33 | $0.43 | 0.1 | N/A | $232.71 M |
| 11/02/2021 | Q1 2022 | $0.28 | $0.16 | -0.12 | N/A | $214.67 M |
| 08/25/2021 | Q4 2021 | $0.31 | $0.42 | 0.11 | N/A | $220.28 M |
| 05/06/2021 | Q3 2021 | $0.34 | $0.30 | -0.04 | N/A | $211.73 M |
In the previous quarter, Phibro Animal Health Corp. (:PAHC) reported $0.87 earnings per share (EPS) to beat the analysts' consensus estimate of $0.69 by $0.18.
The conference call for Phibro Animal Health Corp.'s latest earnings report can be listened to online.
The conference call transcript for Phibro Animal Health Corp.'s latest earnings report can be read online.
Phibro Animal Health Corp. (:PAHC) has a recorded annual revenue of $1.30 B.
Phibro Animal Health Corp. (:PAHC) has a recorded net income of $48.26 M.Phibro Animal Health Corp. has generated $1.19 earnings per share over the last four quarters.
Phibro Animal Health Corp. (:PAHC) has a price-to-earnings ratio of 23.24 and price/earnings-to-growth ratio is 0.65.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED